DuPont de Nemours (NYSE:DD – Get Free Report) updated its second quarter 2026 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of 1.750-1.750 for the period, compared to the consensus earnings per share estimate of 1.770. The company issued revenue guidance of -. DuPont de Nemours also updated its FY 2026 guidance to 7.020-7.160 EPS.
DuPont de Nemours Stock Performance
DuPont de Nemours stock opened at $46.67 on Wednesday. DuPont de Nemours has a 12-month low of $28.07 and a 12-month high of $52.66. The company has a debt-to-equity ratio of 0.22, a current ratio of 2.68 and a quick ratio of 2.11. The company has a market capitalization of $18.90 billion, a price-to-earnings ratio of -777.70, a price-to-earnings-growth ratio of 1.37 and a beta of 1.03. The firm’s fifty day moving average price is $47.70 and its 200 day moving average price is $45.83.
DuPont de Nemours (NYSE:DD – Get Free Report) last announced its earnings results on Tuesday, May 5th. The basic materials company reported $1.65 earnings per share for the quarter, beating the consensus estimate of $1.44 by $0.21. DuPont de Nemours had a positive return on equity of 7.15% and a negative net margin of 0.30%.The company had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. During the same period last year, the firm earned $3.09 earnings per share. The company’s revenue was up 4.3% on a year-over-year basis. DuPont de Nemours has set its Q2 2026 guidance at 0.590-0.590 EPS and its FY 2026 guidance at 2.350-2.400 EPS. On average, research analysts forecast that DuPont de Nemours will post 2.38 EPS for the current fiscal year.
DuPont de Nemours Increases Dividend
Wall Street Analyst Weigh In
A number of equities analysts have issued reports on the company. Citigroup cut their target price on DuPont de Nemours from $177.00 to $168.00 and set a “buy” rating on the stock in a research report on Monday, April 13th. Royal Bank Of Canada raised their price target on shares of DuPont de Nemours from $168.00 to $180.00 and gave the stock an “outperform” rating in a research report on Monday, May 11th. Zacks Research upgraded shares of DuPont de Nemours from a “hold” rating to a “strong-buy” rating in a research note on Thursday, June 18th. UBS Group upped their price target on shares of DuPont de Nemours from $168.00 to $177.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Finally, The Goldman Sachs Group initiated coverage on shares of DuPont de Nemours in a research note on Monday, June 15th. They set a “neutral” rating and a $159.00 price objective on the stock. One research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $165.20.
Get Our Latest Analysis on DuPont de Nemours
Institutional Investors Weigh In On DuPont de Nemours
A number of institutional investors have recently made changes to their positions in the company. Palisade Asset Management LLC acquired a new position in DuPont de Nemours in the third quarter worth $26,000. Imprint Wealth LLC acquired a new stake in shares of DuPont de Nemours during the third quarter worth $27,000. Measured Wealth Private Client Group LLC acquired a new stake in shares of DuPont de Nemours during the third quarter worth $30,000. Atlas Capital Advisors Inc. bought a new position in shares of DuPont de Nemours in the 4th quarter worth about $38,000. Finally, Ameriflex Group Inc. boosted its holdings in shares of DuPont de Nemours by 5,940.0% in the 4th quarter. Ameriflex Group Inc. now owns 1,208 shares of the basic materials company’s stock valued at $49,000 after buying an additional 1,188 shares during the period. 73.96% of the stock is currently owned by institutional investors.
DuPont de Nemours Company Profile
DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.
DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.
Recommended Stories
- Five stocks we like better than DuPont de Nemours
- Why nVent Could Be a Long-Term AI Infrastructure Winner
- Oracle’s Sell-Off Looks More Like a Mispricing Than a Warning
- Apple’s Intel Deal Arrives at the Right Time for Its Stock
- Liquid Gold: The AI Cooling Retrofit Trade
Receive News & Ratings for DuPont de Nemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DuPont de Nemours and related companies with MarketBeat.com's FREE daily email newsletter.
